Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2011, Vol. 31 Issue (02): 1-6    DOI:
    
In vivo Bioluminescence Imaging of Luc Labeled Human PSCA-expressed Tumor in Mouse Model
DONG Lei1,2, ZHANG Xiao-peng1, YI Shao-qiong1, MAO Ya-li3, YU Ting1, HOU Li-hua1, FU Ling1, YU Chang-ming1, CHEN Wei1
1. Department of Molecular Biology, State Key Laboratory of Pathogens and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China;
2. Clinical Laboratory Center, The General Hospital of PLA Air Force, Beijing 100142, China;
3. Department of Pharmacology, The General Hospital of PLA Air Force, Beijing 100142, China
Download: HTML   PDF(1493KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objectives:To establish a tumor model in mouse with expressing Luc and human PSCA for the development of new anti-tumor drugs or vaccines. Methods:The Luc and human PSCA genes were cloned and pcDNA-luc and pcDNA-PSCA plasmids were constructed. RM-1 cells were stably transfected with both pcDNA-luc and pcDNA-PSCA plasmids. The Luc-expressed cells were examined with luminometer and the PSCA-expressed cells were examined with RT-PCR and flow cytometry analysis. The male C57BL/6 mice were inoculated with RM-PSCA/Luc cells, then the growth and the survival time of mice were measured, respectively. In vivo bioluminescence imaging was used to detect Luc expression and immunohistochemistry analysis was used to detect PSCA expression. Results:RM-PSCA/Luc cells stably expressing Luc and PSCA were obtained and can establish tumor growth in 100% of inoculated mice. Conclusion:The Luc-expressed and PSCA-expressed tumor model in mice was successfully established and could be used for evaluating the activities of drugs or vaccines.



Key wordsLuciferase      PSCA      Tumor model     
Received: 01 November 2010      Published: 18 February 2011
ZTFLH:  Q819  
Cite this article:

DONG Lei, ZHANG Xiao-peng, YI Shao-qiong, MAO Ya-li, YU Ting, HOU Li-hua, FU Ling, YU Chang-ming, CHEN Wei. In vivo Bioluminescence Imaging of Luc Labeled Human PSCA-expressed Tumor in Mouse Model. China Biotechnology, 2011, 31(02): 1-6.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2011/V31/I02/1

[1] Ntziachristos V, Ripoll J, Wang L V, et al. Looking and listenting to light: the evolution of whole-body photonic imaging. Nat Biotechnol, 2005, 23(3): 313-320.
[2] Notting I C, Buijs J T, Que I, et al. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Invest Ophthalmol Vis Sci, 2005, 46(5): 1581-1587.
[3] Contag P R, Olomu I N, Stenvenson D K, et al. Bioliminescent indicators in living mammals. Nat Med, 1998, 4(2): 245-247.
[4] Reiter R E, Gu Z, Watabe T, et al. Prostate stem cell antigen: a cellsurface maker overexpressed in prostate cancer. Natl Acad Sci USA, 1998, 95(4):1735-1740.
[5] Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 2000, 19(10): 1288-1296.
[6] Bahrenberg G, Brauers A, Joost H G, et al. PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112. Cancer Lett, 2001, 168: 37-43.
[7] Wang X L, Rosol M, Ge S D, et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescene imaging. Blood, 2003, 102: 3478-3482.
[8] 张海燕,李艳,王喆,等.用于活体成像的小鼠肺癌移植瘤模型的建立.生物工程学报,2009,25(8):1204-1210. Zhang H Y,Li Y,Wang Z,et al.Chinese Journal of Biotechnology,2009,25(8):1204-1210.
[9] 杜子婧,杨湄,昝涛,等.荧光素酶报告基因在干细胞体内示踪研究中的应用.组织工程与重建外科杂志,2010,6(1):52-55. Du Z J,Yang M,Zan T,et al.Journal of Tissue Engineering and Reconstructive Surgery,2010,6(1):52-55.

[1] ZHAO Yuan-bo, HONGDu Bei-qi, CHEN Ying-yu. Establishment of p62/SQSTM1-luciferase Based Method for Cellular Autophagic Flux Determination[J]. China Biotechnology, 2016, 36(1): 55-62.
[2] YE Yu-chen, ZHAO Jun-long, WANG Lin, DUAN Juan-li, GAO Chun-chen, QIN Hong-yan, DOU Ke-feng. Construction of A Cell Line EGFP-Luc-Hepa1-6 and Its Application in the Mouse Model of the Hepatoma[J]. China Biotechnology, 2015, 35(5): 1-7.
[3] LI Hong-yi, XI Qian-yun, ZHANG Yong-liang. Identification miRNAs That Regulate Porcine TNF-α Expression Through Targeting TNF-α UTR[J]. China Biotechnology, 2014, 34(10): 35-40.
[4] LI Bing-juan, LI Yu-xia, LI Bei-ping, LING Yan, ZHOU Wei, LI Wei-dong, LIN Hai-long, LIANG Long, LIU Gang, ZHANG Jin-hai, CHEN Hui-peng. Construction and Evaluation of the Mutated Anthrax Toxin Proteins as Drug Deliver System for Targeting Tumor Cells[J]. China Biotechnology, 2013, 33(4): 1-8.
[5] FAN Li-xia, GAO An-hui, ZHOU Yu-bo, LI Jia. Establishment of a Cell-based High-throughput Screening Model Targeting the IRE1/XBP1 Signaling Pathway[J]. China Biotechnology, 2012, 32(01): 73-80.
[6] . Immobilization of Luciferase by Cloning and Expression of Biotinylated Luciferase[J]. China Biotechnology, 2007, 27(9): 41-46.
[7] . Construction and expression in vitro of RU486-inducible regulatory vector[J]. China Biotechnology, 2007, 27(6): 1-5.
[8] . The SARS-CoV 3a and 7a protein may enhance the induction of IFN-β[J]. China Biotechnology, 2006, 26(12): 6-10.